AIG
IPSC icon

American International Group’s Century Therapeutics IPSC Stock Holding History

American International Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,543
Closed -$48.3K – 1327
2024
Q1 		$48.3K Sell
11,543
-100
-0.9% -$423 ﹤0.01% 2795
2023
Q4 		$38.7K Sell
11,643
-46
-0.4% -$84 ﹤0.01% 2869
2023
Q3 		$23.4K Buy
11,689
+416
+4% +$1.11K ﹤0.01% 2968
2023
Q2 		$35.6K Buy
11,273
+1,554
+16% +$5.01K ﹤0.01% 2951
2023
Q1 		$33.7K Buy
9,719
+193
+2% +$848 ﹤0.01% 2809
2022
Q4 		$48.9K Sell
9,526
-35
-0.4% -$330 ﹤0.01% 2757
2022
Q3 		$95K Buy
9,561
+136
+1% +$1.43K ﹤0.01% 2584
2022
Q2 		$79K Buy
9,425
+821
+10% +$8.05K ﹤0.01% 2713
2022
Q1 		$108K Buy
8,604
+2,328
+37% +$30.8K ﹤0.01% 2564
2021
Q4 		$100K Sell
6,276
-187
-3% -$3.51K ﹤0.01% 2715
2021
Q3 		$163K Buy
+6,463
New +$175K ﹤0.01% 2550

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

American International Group's IPSC Position: Q2 2024 in Review

American International Group sold out of Century Therapeutics (IPSC) in Q2 2024, closing a stake of 11,543 shares — an estimated $48.3K sold.

American International Group first reported a position in IPSC in Q3 2021 and held it in 11 quarters. The position peaked at $163K in Q3 2021. 61 funds tracked by Wall St. Rank hold IPSC as of Q2 2024.

  • American International Group reported no remaining Century Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 11,543 Century Therapeutics shares in Q2 2024, an estimated $48.3K.
  • American International Group first reported a position in Century Therapeutics in Q3 2021 and held it in 11 quarters.
  • American International Group's Century Therapeutics position peaked at $163K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.